# Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

> **NCT00874549** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 216 (actual)

## Conditions studied

- Meningococcal Infections
- Meningococcal Meningitis

## Interventions

- **BIOLOGICAL:** Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide
- **BIOLOGICAL:** Menactra®: Polysaccharide Diphtheria Toxoid Conjugate
- **BIOLOGICAL:** Menactra®: Polysaccharide Diphtheria Toxoid Conjugate
- **BIOLOGICAL:** Menactra®: Polysaccharide Diphtheria Toxoid Conjugate

## Key facts

- **NCT ID:** NCT00874549
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-10
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00874549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00874549, "Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00874549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*